Back

Development and validation of a 2-year MACCE prediction model incorporating routine biomarkers in young patients with premature coronary heart disease: a multicenter study

30 August 2026 (09:15 - 09:40)
Organised by: Logo
Congress Presentation Part of: Predicting risk of future heart disease Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Jingjing Xu

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

2 More presentations in this session

Presentation thumbnail
Comparative performance of CTI-based adiposity indices for incident CVD: insights from CHARLS
Doctor F. Zhang (Beijing, CN)
Presentation thumbnail
Increased C-reactive protein–triglyceride glucose index is associated with the incidence of hypertension in individuals without hypertension: a large-scale retrospective cohort study
Miss Y. Su (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Predicting risk of future heart disease

The Event

Event poster

ESC Congress 2026

30 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of vascular inflammation biomarkers over clinical risk factors for cardiovascular risk : a meta-analysis
17 April 2021
thumbnail
Congress Presentation
Determinants and clinical outcomes of premature acute coronary syndrome
21 March 2026
thumbnail
Congress Presentation
Clinical prediction model of main adverse cardiovascular and cerebrovascular events for elderly patients with acute coronary syndrome
31 August 2024
thumbnail
Congress Presentation
External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy
29 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources